Results of a Phase 1 Study of AME-133v (LY2469298), an Fc-Engineered Humanized Monoclonal Anti-CD20 Antibody, in FcγRIIIa-Genotyped Patients with Previously Treated Follicular Lymphoma

Overview of attention for article published in Clinical Cancer Research, March 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (92nd percentile)
High Attention Score compared to outputs of the same age and source (85th percentile)

Mentioned by

twitter: 1 X user
patent: 45 patents

wikipedia: 1 Wikipedia page

Readers on

mendeley: 52 Mendeley

So far, Altmetric has seen 1 Wikipedia article.

Ocaratuzumab

Cited by user Boghog on 27 Dec 2020

Ocaratuzumab (AME-133v, LY2469298) is a humanized monoclonal antibody designed for the treatment of cancer and autoimmune disorders.

This page shows the most recent Wikipedia articles that mention this research output. Click here to find out how to access more activity.